Meningococcal disease
Showing 1 - 25 of >10,000
Epidemiological, Clinical and Biological Caracteristics of
Recruiting
- Meningococcal Infections
- There is no intervention
-
Poitiers, Vienne, FrancePoitiers University
Aug 8, 2023
Propositive Follow-up Study
Recruiting
- HIV/AIDS
- Meningococcal Disease
- Serum Bactericidal Assays
-
London, United KingdomSt George's University of London
Jan 27, 2022
Meningitis, Meningococcal Meningitis, Meningococcal Infections Trial in United States (Meningococcal Polysaccharide (A, C, Y,
Completed
- Meningitis
- +3 more
- Meningococcal Polysaccharide (A, C, Y, and W 135) Tetanus Protein Conjugate Vaccine
- Meningococcal Polysaccharide Vaccine, Groups A, C, Y, W 135 Combined
-
Chandler, Arizona
- +11 more
Mar 24, 2022
Meningococcal Disease, Invasive Trial in Calgary, Vancouver, Halifax (MenACWY-CRM, MenACWY-DT, MenACWY-TT)
Completed
- Meningococcal Disease, Invasive
- MenACWY-CRM
- +2 more
-
Calgary, Alberta, Canada
- +2 more
Mar 10, 2022
Meningitis, Meningococcal Trial in Liuzhou, Nanning (Meningococcal ACYW135 Polysaccharide Conjugate Vaccine, Meningococcal A and
Recruiting
- Meningitis, Meningococcal
- Meningococcal ACYW135 Polysaccharide Conjugate Vaccine
- Meningococcal A and C Polysaccharide Conjugate Vaccine
-
Liuzhou, Guangxi, China
- +1 more
Feb 13, 2022
Meningitis, Meningococcal Trial in Liuzhou (Meningococcal ACYW135 Polysaccharide Conjugate Vaccine)
Completed
- Meningitis, Meningococcal
- Meningococcal ACYW135 Polysaccharide Conjugate Vaccine
-
Liuzhou, Guangxi, ChinaRongan Center for Disease Control and Prevention
Feb 9, 2022
Meningococcal Invasive Infections at Participating Centers
Recruiting
- Invasive Meningococcal Disease
- surveillance
-
Calgary, Alberta, Canada
- +12 more
Apr 4, 2022
Meningococcal Infections Trial in Oakland, Worcester (Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals))
Completed
- Meningococcal Infections
- Trumenba Vaccine (Wyeth/Pfizer Pharmaceuticals)
-
Oakland, California
- +1 more
Feb 1, 2021
Gonococcal Infection Trial in Thailand, United States (Meningococcal Group B Vaccine, Placebo)
Recruiting
- Gonococcal Infection
- Meningococcal Group B Vaccine
- Placebo
-
Birmingham, Alabama
- +8 more
Aug 18, 2022
Sources of COmplement in Meningococcal and Pertussis Serum
Unknown status
- Pertussis
- +2 more
- Cord blood sampling
-
London, United KingdomSt George's, University of London
Jan 8, 2021
Vaccine for Meningococcal Disease Trial in India (NmCV-5, Menactra)
Completed
- Vaccine for Meningococcal Disease
- NmCV-5
- Menactra
-
New Delhi, Delhi, India
- +10 more
Sep 4, 2021
Dengue Virus, Dengue Fever, Dengue Hemorrhagic Fever Trial in Long Xuyên (CYD dengue vaccine serotypes (1, 2, 3, 4).,
Completed
- Dengue Virus
- +3 more
- CYD dengue vaccine serotypes (1, 2, 3, 4).
- Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide
-
Long Xuyên, An Giang Province, VietnamSanofi Pasteur Investigational Site
Mar 15, 2022
Invasive Meningococcal Disease in Australian Adolescents and
Recruiting
- Meningococcal Infections
- +2 more
-
Westmead, New South Wales, Australia
- +3 more
Oct 11, 2020
Meningitis, Meningococcal Trial in Kunming (Experimental Group A meningococcal polysaccharide vaccine, Control Group A
Recruiting
- Meningitis, Meningococcal
- Experimental Group A meningococcal polysaccharide vaccine
- Control Group A meningococcal polysaccharide vaccine
-
Kunming, Yunnan, ChinaYunnan Center for Disease Control and Prevention
Dec 28, 2020
Meningoccocal Disease, Meningococcal Meningitis Trial in Hungary, Spain (Bexsero® vaccine (1 dose at study month zero), Bexsero®
Completed
- Meningoccocal Disease
- Meningococcal Meningitis
- Bexsero® vaccine (1 dose at study month zero)
- Bexsero® vaccine (2 doses 1 month apart)
-
Debrecen, Bajcsi Ut 32, Hungary
- +16 more
Nov 24, 2021
Meningitis, Meningococcal Trial in Kunming (Experimental Group A and C meningococcal polysaccharide vaccine, Control Group A and
Recruiting
- Meningitis, Meningococcal
- Experimental Group A and C meningococcal polysaccharide vaccine
- Control Group A and C meningococcal polysaccharide vaccine
-
Kunming, Yunnan, ChinaYunnan Center for Disease Control and Prevention
Dec 28, 2020
Meningococcal Disease, Infections, Meningococcal Trial in Taipei (Bexsero®, Routine vaccines)
Completed
- Meningococcal Disease
- Infections, Meningococcal
- Bexsero®
- Routine vaccines
-
Taipei, Taiwan
- +1 more
Aug 13, 2020
Hand, Foot and Mouth Disease Trial in Dongguan (Concomitant administration of EV71 vaccine with EPI vaccines, Single injection
Completed
- Hand, Foot and Mouth Disease
- Concomitant administration of EV71 vaccine with EPI vaccines
- +2 more
-
Dongguan, Guangdong, ChinaDongguan Municipal Center for Disease Control and Prevention
Jul 26, 2021
Prematurity, Vaccination, Meningococcal Disease Trial in Tooting (4CMenB Vaccine)
Completed
- Prematurity
- +2 more
- 4CMenB Vaccine
-
Tooting, London, United KingdomSt Georges University Hospital NHS Foundation Trust
Nov 30, 2020
Meningococcal Disease, Pneumococcal Disease, Haemophilus Influenzae Serotype b Disease Trial in London (Menjugate, Menitorix,
Completed
- Meningococcal Disease
- +4 more
- Menjugate
- +2 more
-
London, United KingdomSt George's Vaccien Institute
Sep 29, 2020
Splenectomy; Status Trial (Bexsero)
Not yet recruiting
- Splenectomy; Status
- Bexsero
- (no location specified)
Aug 29, 2023
Immunisation for Adolescents Against Serious Communicable
Not yet recruiting
- Gonorrhea
- Meningococcal Disease
- Licenced 4CMenB Vaccine
- (no location specified)
May 18, 2020
PRIME Follow up - Quadri Meningo Vacinees
Completed
- Meningococcal Disease
- venepuncture only
- (no location specified)
Mar 2, 2020
Meningococcal Disease, Infections, Meningococcal Trial in Santiago, Bogota, Panama City (MenABCWY+OMV vaccine)
Completed
- Meningococcal Disease
- Infections, Meningococcal
- MenABCWY+OMV vaccine
-
Santiago, Chile
- +6 more
Jun 24, 2020
Gonorrhea Trial in Kilifi (4CMenB (Bexsero®) vaccine)
Completed
- Gonorrhea
- 4CMenB (Bexsero®) vaccine
-
Kilifi, KenyaKEMRI-Wellcome Trust Research Programme
Apr 13, 2022